Novo Nordisk Files Federal Lawsuit Against Eli Lilly Over GLP-1 Drug Advertising
Novo Nordisk filed a federal Lanham Act lawsuit against Eli Lilly on Monday, accusing Zepbound's maker of running misleading GLP-1 drug advertisements in the first known courtroom clash between the obesity market

Follow